purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation gmed earnings call period ending december image source motley fool globus medical gmed q earnings callfeb pm etcontents prepared remark question answer call participant prepared remark operatorgood day thank standing welcome globus medical fourth quarter full year earnings call time participant listenonly mode speaker presentation questionandanswer session operator instruction please advised today conference recorded would like hand conference first speaker today brian kearns senior vice president business development investor relation please go aheadbrian kearns senior vice president business development investor relation thank victor thank everyone u today joining today call globus medical dan scavilla president ceo keith pfeil chief operating chief financial officer review made available via webcast accessible investor relation section globus medical website wwwglobusmedicalcom begin let remind statement made review may considered forwardlooking statement form k fiscal year subsequent filing security exchange commission identify certain factor could cause actual result differ materially projected forwardlooking statement made today sec filing including k available website undertake update forwardlooking statement result new information future event development discussion today also include certain financial measure calculated accordance generally accepted accounting principle gaapwe believe nongaap financial measure provide additional information pertinent business performance nongaap financial measure considered replacement read together directly comparable gaap financial measure reconciliation directly comparable gaap measure available schedule accompanying press release investor relation section globus medical website turn call dan scavilla president ceo dan scavilla executive vice president chief commercial officer president trauma thanks brian good afternoon everyone globus finished strong performance fourth quarter revenue full year record billion delivering million revenue growth versus prior year including four month innovation sale achieve record sale maintaining industryleading profitability generating record nongaap eps adjusted ebitda even continue strong investment enabling technology orthopedics competitive recruiting also achieved significant progress integrating nuvasive merger continue fuel innovation five new product launched positioning u well gain momentum q delivered record sale million growing million q nongaap eps adjusted ebitda also record free cash flow million cash used fuel growth funding innovative launch product set expansion inhouse manufacturing briefly comment standalone globus standalone nuvasive q revenue however become one company one focus provide standalone company information going forward globus standalone sale q million increasing million growth versus prior year delivering adjusted ebitda sale driven continued market growth yous spine increasing momentum internationally growth strong performance trauma gain enabling technology delivered growth q driven higher unit placement offset product mix country mix financing program robotic procedure performed date growing foundation remains strong proud globus team delivering solid growth profitability enter nuvasive standalone sale q million pro forma basis primarily driven continued market penetration international spine growth market reentry key technology nuvasive specialty orthopedics delivering gain strengthened nuvasive clinical service increasing versus prior year partially offset slight decline yous spine attributed deal dissynergies lower pull sale impacted customer uncertainty merger date seen sale synergy territory fall well within projected estimate provided former nuvasive team key growth driver crossselling enabling tech penetration look forward partnering q launched victory lumbar fixation plate buttress plate anterior lateral anteriorlateral approach adding broad spinal fixation platform entering combined product pipeline full setting stage strong year product introduction next month adding bestinclass expandable portfolio new inr offering including ehub navigation system seamless navigation combined ed system expansion precise trauma nailing system moving integration status starting deal rationale merger nuvasive created leading worldclass organization global scale expanded customer reach minimal sale force overlap comprehensive innovative portfolio spine enabling tech orthopedics position u well longterm sustained growth combined product development team focus rapid development innovative solution address unmet clinical need continuum care bring procedural solution marketplace surge education research program define u thought leader shaping marketplace expanding complementary operational footprint improves inhouse capability support commercial growth drive cost saving financial discipline provides ability redirect investment focused growth area improving combined profitability cash flow commercial front completed realignment yous international sale team january implemented new team structure support surgeon throughout world also held several education session rep product crosstraining enabling tech education remain track implementing common operating system q allow u work one company one team pleased work look forward driving meaningful growth new structure also continue receive significant inbound interest competitive sale professional seeking opportunity carry bag second none combined company destination choice sale personnel cherish incredible product portfolio financial security longevity one immediate benefit merger crossselling existing portfolio made significant investment key product set ramping crossselling mentioned salesforce crosstraining continuing planned accelerate crossselling opportunity throughout set become available also made significant investment long lead time component manufacturing resource scale enabling tech capacity allowing increased production output preparation higher demand reorganizing product development carrying forward rich history rapid development remain industry thought leader work surgeon partner address unmet clinical need pioneering xlif procedure gold standard lateral surgery leading market expandable cage technology developing best spinal robot advanced intraoperative ct imaging working create surgical proceduralization key spine surgery create standard care across spine industry intellectual property portfolio spinal industry last decade committed expanding lead especially enabling tech arena continue forefront imaging navigation robotics accomplish remain committed continuing existing project strong pd presence west coast focused spine enabling tech solution enhancing surgeon engagement program increase impact surgeon strengthen interact aspect business professional affair team expanded added scientific affair marketing communication team talented individual addition increasing research clinical investment expanding coordination education program enhancing presence teaching institution operation remains strength merger begun expanding inhouse capability west carrollton production facility part ongoing synergy memphis distribution center capable supporting expanded distribution combined entity continue invest hightech manufacturing equipment implant instrumentation enabling tech production capability also working consolidate volume order thirdparty vendor accelerate delivery time drive cost saving activity progressing planned synergy target identified focusing outofpocket spending prioritizing investment match future growth plan inhouse organizational structure implemented reach steady state midyear employee impacted merger reorganization slash burn exercise merger payback driven deep employee spending cut remain focused building organization support longterm sustained profitable growth want conclude sharing recent event reminded recently held combined yous national sale meeting coming together one team first time since merger commercial restructuring interesting watch hesitancy participant evaporate saw familiar face teammate worked worked competed combined wellbalanced leadership team showed sale force really bringing best organization together support create onceinacareer opportunity first evening product fair could longer tell came globus came nuvasive one strong energy room focused combined portfolio innovation genuine excitement get back field win team meeting reconfirmed belief really alike different combined unstoppable wait international sale meeting make feeling global believe potential globus never greater u harness resource shape future market fingertip everything need realize closing want congratulate keith pfeil recent welldeserved promotion chief operating officer cfo keith rocksolid leader great partner well suited role turn call keithkeith pfeil chief operating officer chief financial officer dan thank good afternoon everyone joining u today call year past initial february th merger announcement reporting today first full quarter merged entity comment today focus q full year result provide insight view performance provide update integration synergy tracking well commenting longerterm capital allocation priority comment q full year focus asreported result providing update legacy globus business performance well summary comment contribution nuvasive asreported basis reminder information presented done based globus accounting policy consistently applied asreported result legacy globus legacy nuvasive q revenue million asreported basis constant currency basis prioryear quarter net income million resulting fully diluted gaap earnings per share reflective mergerrelated cost expense q nongaap net income million resulted fully diluted nongaap earnings per share q nongaap net income grew nongaap eps grew prioryear quarter driven higher share count result merger nuvasive illustrate q fully diluted share million versus million share prior year quarter q adjusted ebitda free cash flow generated totaled million full year revenue billion growing asreported constant currency basis day adjusted sale growth one le selling day compared net income million resulted fully diluted earnings per share reflective deal integration cost associated nuvasive merger nongaap net income million delivering fully diluted nongaap earnings per share full year nongaap net income grew prior year nongaap earnings per share grew prior year lower growth rate pershare basis driven increased share count result stockforstock merger nuvasive full year adjusted ebitda generated million free cash flow moving revenue musculoskeletal sale fourth quarter million growing reported compared prior year quarter legacy globus musculoskeletal sale q million higher prioryear quarter growth led yous international spine business well continued share growth within trauma q enabling technology revenue million growing compared prioryear quarter legacy globus enabling technology revenue million growing prior year record unit placed capital continued see strong uptake quarter however revenue growth tempered based country mix financing arrangement turning attention geographic sale yous revenue fourth quarter million growing prioryear quarter legacy globus yous revenue fourth quarter million growing reported compared prior year quarter increase sale led primarily continued yous spine growth international revenue fourth quarter million growing reported compared prior year legacy globus international revenue q million higher versus prioryear quarter driven strong implant growth within key focus country including australia brazil italy japan spain united kingdom gaap gross profit fourth quarter versus prioryear quarter decrease gaap gross profit driven impact nuvasive merger namely stepup inventory amortization adjusted gross profit excludes impact inventory stepup amortization expect continue report consolidated adjusted gross profit metric next several quarter stepup amortization impact gaap gross profit fiscal legacy globus gaap gross profit fourth quarter compared prioryear quarter driven lower product cost result higher mix spine implant sale full year gaap gross profit compared prior year driven impact stepup amortization result nuvasive merger adjusted gross profit excludes impact inventory stepup amortization legacy globus gaap gross profit full year line prior year despite legacy enabling technology sale growing prior year reflects impact continued manufacturing supply chain cost saving initiative looking ahead expect adjusted gross profit rate mid upper full year begin realize supply chain saving namely lower freight warehousing expense research development expense q million sale compared million sale prioryear quarter increased spending dollar percentage sale reflective primarily impact nuvasive merger legacy globus q rd expense million sale compared million sale prior year reflective continued investment within enabling technology portfolio partially offset leverage impact higher sale full year research development expense million sale compared million sale prior year increase driven primarily impact nuvasive merger legacy globus rd expense million sale compared million sale increased spending driven primarily enabling technology investment looking ahead expect rd expense range sga expense fourth quarter million sale compared million sale prioryear quarter reflecting impact nuvasive merger legacy globus sga expense fourth quarter million sale consistent prior year full year sga expense million sale compared million sale prior year reflects impact nuvasive merger legacy globus sga expense million sale reflects slightly higher people cost driven benefit travel well increased bad debt expense driven onetime benefit prior year repeat current year looking ahead expect full year sga improve percentage point full year sga expense look ahead fiscal expect interest expense headwind driven two factor first invested cash balance lower year year driven paydown former nuvasive line credit merger close decreased cash balance million thus decreasing interest income moving forward second item relates interest expense senior convertible note interest expense note occur two part first cash portion based rate secondly noncash interest portion driven amortization fair value adjustment note time merger estimate interest expense range million million fiscal versus net interest income million fiscal gaap tax rate quarter compared q primarily driven impact nondeductible merger cost lower gaap pretax income normalized basis nongaap effective tax rate fourth quarter full year effective tax rate compared prior year resulting increase driven impact mergerrelated cost expect repeat future looking ahead expect full year effective tax rate approximately shifting cash liquidity cash cash equivalent marketable security million december st shortterm borrowing unsecured line credit yearend longterm borrowing consist senior convertible note due assumed part merger nuvasive remains intent note part capital structure due settled march turning attention cash flow q net cash provided operating activity million q free cash flow million free cash flow grew million prioryear quarter approximately million growth driven legacy globus remainder driven contribution nuvasive merger net cash provided operating activity million free cash flow million looking ahead expect capex spending within range sale full year basis consistent history capital allocation priority remain unchanged moving ahead primary use capital fund internal investment product development inventory capex facilitating complementary meet need strategy moving forward near term would expect inorganic opportunity tuckin type deal opposed transformative deal especially continue integrate nuvasive merger though organic inorganic investment primary us capital continue utilize share repurchase within capital structure coming fourth quarter total million authorized board director fund share repurchase fourth quarter spent total million repurchase approximately million share average price per share company approximately million remaining authorized share repurchase program shifting attention cost saving synergy still expect generate total million synergy three year result merger nuvasive realized year one end year two year three since last shared update taken step begin realize synergy saving focus saving across business centered operation namely warehouse contract negotiation sga cost redundancy elimination duplicative thirdparty expense well start system integration activity move would expect synergy saving increase sequentially quarter action planned realized dan noted moving ahead slash burn exercise cost cut rather cut focused key area drive greater value creation primary focus fiscal drive recurring cost saving area manufacturing sourcing thirdparty supplier contract renegotiations product sourcing well investment machinery equipment also drive greater manufacturing efficiency also drive greater fixed cost leverage within manufacturing supply chain present time feel confident achieving energy target set forth beyond continue provide update year progress present time company reaffirming previously provided financial guidance project net sale range billion billion dollar fully diluted nongaap earnings per share range net sale guidance includes projected sale dissynergies roughly million result nuvasive merger adjusting sale dissynergies projected revenue growth would approximately based fiscal pro forma revenue billion nongaap earnings per share guidance implies growth assumes approximately million fully diluted share full year versus actual share million fully diluted share look key success focus ability execute near term continue merger integration goal moving back toward steady state midyear tremendous effort continue bringing new organization together push forward gotomarket strategy key geography internally continue drive synergy capture key focus continued operational improvement focus execution value creation drive shareholder value seek achieve goal set forth creating enhanced profitability cash flow generation goal improve musculoskeletal care achieve procedural innovation innovation achieved listening customer patient surgeon successful need listen need focus execute customer constant contact active listening continue bring bestinclass innovation market separate competition remain excited future want thank entire globus team relentless effort pursuit excellence operator open call question question answer operatoroperator instruction first question come line vik chopra well fargo line openvik chopra well fargo security analyst hey good afternoon thanks much taking question two appreciate color integration effort maybe talk surprised upside well downside followup question thankskeith pfeil chief operating officer chief financial officer thanks vik keith take upside downsize relates cost think dig start look business continues great opportunity operational improvement manufacturing think bringing facility together manufacturing legacy nuvasive really allows fixed cost leverage improvement cost saving generated overnight commented prepared remark going looking investing new machinery equipment got get online got start produce inventory think see saving going backside would also say sga look today think continuing overlay kind globus approach spending think opportunity saying dan commented know slash burn exercise thing commented place spending money talked scientific affair talked surge outreach place invest drive business moving forwarddan scavilla executive vice president chief commercial officer president trauma yeah add vik know one thought think upside really willingness team come together embrace common different readiness field also inhouse support really came together way thought great know downside would unsexy thing heavy lifting need common process common report common system know need go run drive infrastructure big surprise quite fun go much innovation much room go growvik chopra well fargo security analyst great thanks color follow think said inbounds competitive rep maybe talk meaningful conversation broad trend hiring q see recruiting retention effort shaking thank youdan scavilla executive vice president chief commercial officer president trauma yeah got couple thing let u start first part really lot foot traffic right competitive people coming expressing interest proactively u meaningful large size well established certainly significant taking time make sure going would tell recruiting general strong lighter past two year guess could cheat technically say hired competitive rep fourth quarter meaning focus obviously counterpart getting done result quite heavy recruiting main focus get back pleased see far quarter trafficoperatorthank one moment next question next question come line steve lichtman oppenheimer line opensteve lichtman oppenheimer company analyst thank hi guy keith mentioned prepared remark relative enabling technology financing arrangement seeing mix placement versus outright sale something look guy particularly new competitor hit marketdan scavilla executive vice president chief commercial officer president trauma great question thanks would say q saw volumebased sale know difference every year interest rate higher think rev rec revenue recognition occurred greater portion went interest income recognized radically life deal talk growth base business really driven primarily interest impact really think moving forward see volumebased arrangement think going ebb flow quarter quarter would say start inflection point going driving volumebased really going driven customer really looking forsteve lichtman oppenheimer company analyst got great secondly term ortho business think aaos guy talked potentially showing knee system year level investment going required get business ground embedded fy earnings commentarydan scavilla executive vice president chief commercial officer president trauma steve talking robot implant bothsteve lichtman oppenheimer company analyst bothdan scavilla executive vice president chief commercial officer president trauma ok would make tougher robot actually built yet approved something would built significance great updated product cementless pressfit knee coming revision update light building forecast yet get get approval look upside would signal anticipated second half year seen anything would take u course conservative fda approval building needed plan achievesteve lichtman oppenheimer company analyst relative level investment required kind get ortho business ground meaningful built yeardan scavilla executive vice president chief commercial officer president trauma would say level investment would meaningful year think development cost know treat expensive development cost incurred hanging expense waiting run pl think know come pl stride one thing would add steve stuff need get market spent past couple year anyway already large level ortho investment built well even earlier see blip model anything would take significantly aresteve lichtman oppenheimer company analyst ok got thanks guysoperatorone moment next question next question come line matt blackman stifel line openmathew blackman stifel financial corp analyst good afternoon everybody thanks taking question got couple keith maybe start bigger picture guidance question curious lens looking gauge guidance historically think guided range high conviction also opportunity upside first question anything changed guidance philosophy combined company one followupkeith pfeil chief operating officer chief financial officer would say know topline guidance something feel confident would say called sale dissynergies wanted get across point know remain extremely excited business growth prospect acknowledging sale dissynergies could exist relates bottom line range think really downthemiddle number mean prepared remark today really sought provide lot color relates gross profitability rd sga expense think kind pull together know seems reasonable obviously always going try beat standing nowmathew blackman stifel financial corp analyst ok appreciate point well give u ton pl stuff work curious really touch ebitda something certainly highlighted proxy recall commentary proxy still best framework number complicated question apologize advance actually look back ebitda outlook proxy think something like million appreciate synergy shifted always change make adjustment timing synergy still coming ebitda number roughly call range right way think something else perhaps change impact ebitda beyond laid proxykeith pfeil chief operating officer chief financial officer great question would say far think make sense think know one thing would say different little bit investment enabling tech year really impacted little bit base business profitability look going forward think range provided make lot sensemathew blackman stifel financial corp analyst right thanks muchoperatorthank one moment next question next question come line shagun singh rbc line openshagun singh rbc capital market analyst great thank much taking question follow guidance provide u give u help cadence call million potential dissynergies think crossselling opportunity included followupkeith pfeil chief operating officer chief financial officer would say million really looking throughout year throughout entire year continuum across business relates crossselling would assumed crossselling guidance number year dan anything would add thatdan scavilla executive vice president chief commercial officer president trauma yeah shagun would tell keith referenced gross number would look offset crossselling growth thing like natural one built netted crossselling going way soften pointshagun singh rbc capital market analyst understood potentially two new competitive spine robot coming market larger market player including one major share donor last several year guess twopart question expect new robotic system compete market relative offering think implant share dynamic company may better ability kind defend position market thank taking questiondan scavilla executive vice president chief commercial officer president trauma yeah great question one really defined got see action taken end day large unmet clinical need got robot superior think even competition called coming year may arrive next month ok know set poised compete way part merger create size reach order also penetrate faster compete fashion think well poised go head head anybody sense would think may choice long term customer focus driving innovation putting product make meaningful differencesshagun singh rbc capital market analyst thank youoperatorone moment next question next question come david saxon needham line opendavid saxon needham company analyst great thanks taking question congrats quarter maybe start integration would love hear feedback getting sale rep following territory integration guy completed november know saying attrition kind line expectation attrition seeing territory kind disrupted thinking filling vacancy competitive rep called outdan scavilla executive vice president chief commercial officer president trauma thanks david know obviously becomes personal matter rep going making change people human nature adapt well appreciate change state uncertainty going quickly quick meaningful honest team worked throughout world fantastic vast majority willing roll sleeve figure work cut space remember thing called clearly low overlap fact time blinded neighborhood u major amount untangling much reorganizing efficient thing area departed may attribute change think sporadic think density certain area would call probably personal comfort comfortable change would like go somewhere else know working filling lot rep need rep looking spread keep eye focused competitive recruiting past year use growth mechanismdavid saxon needham company analyst ok great thanks much wanted ask knee robot launch would love hear strategy around launch like type account going target initially confidence supply manufacturing capacity think stelkast implant ramp kind build robotics install base thanks muchdan scavilla executive vice president chief commercial officer president trauma welcome would tell certainly ordered long lead time component expanded capacity handle merger also feel like set way scaling implant set well slowly right need get get approval go bigger know truth strategy come together little bit second quarter early third quarter get understand launch go would tell open strategy right course need ascs prominent given procedure take place mean take advantage hospital well going globus covering area versus hyperfocused start concentric circle establish invest continue build momentum like done spine yearsdavid saxon needham company analyst great thanks muchoperatorthank one moment next question next question come line matt miksic barclays line openmatt miksic barclays analyst hey great thanks much taking question congrats progress great color maybe dan diving one thing mentioned asc pertains ortho curious could maybe talk little bit shaking opportunity combined business know big globus legacy nuvasive term know percentage business going asc participate growth opportunity spine side one followup coulddan scavilla executive vice president chief commercial officer president trauma yeah got matt disclose certain business segment obviously leave one looking recognize course migration certain cadence procedure go asc appropriate looking understand best way place enabling tech versus freehand navigation versus free hand period working well date still putting together want asc strategy particular area new combined organization significant deviation imagine calling size think one fine tune get better feel stabilized sale force bring together probably stronger push later year matt miksic barclays analyst ok maybe follow integration dynamic know working combination field force everything talked pretty happy way new basis number came q think could speak investor talked opportunity still apprehension start feel like thing tail end downward slope risk maybe dissynergies getting bigger expecting q transitional period think wait q another way signal data point look think help finally put sort concern last year bed appreciate itdan scavilla executive vice president chief commercial officer president trauma yeah great question matt guessing would think would see activity first quarter able understand thought would exiting first quarter second quarter would think touch stable guessing based really one month actual data year way know call steady state june intentionally saying think sale force settled getting learning curve get bump system implementation work cadence really think first quarter second exit second quarter going back best innovate take share growmatt miksic barclays analyst thanks muchoperatorthank one moment next question next question come matthew obrien piper sandler line openmatt obrien piper sandler analyst great thanks taking question guess starter think put standalone nuva standalone gmed together know moving part take dissynergy getting like know million crossselling benefit year number right million dissynergies know seems like lot one year wondering exactly baking know heard texas maybe turning seems like lot one year baked followupdan scavilla executive vice president chief commercial officer president trauma thanks matt well remember globus conservative look estimate putting number would look control beat possible saying slam dunk realistic created market disruption become market expect folk react think would unrealistic think would lose stuff estimate really based factor calling certain geography would comment like said topside number area build look go waymatt obrien piper sandler analyst ok even low overlap mean seems like big numberkeith pfeil chief operating officer chief financial officer mean would say large number step back look sale look combined sale dans point earlier gross number consider crossselling opportunity offset bringing portfolio together going looking legacy nuvasive team going looking globus expendable cage going looking globus enabling technology look nuvasive product legacy globus rep going looking nuvasive lateral procedure crossselling crossselling end day imprecise size basing seedan scavilla executive vice president chief commercial officer president trauma yeah saw say sale could disrupted right middle came number say ok gross number beat costselling growth natural account competitive hiring saying putting saying based formula picked historical norm would number would put go beat outgrowing itmatt obrien piper sandler analyst got ok appreciate keith far back matt blackmans question ebitda think guy said deal know year three post closing would back kind mids far ebitda go mean guidance like kind low lot leverage expecting next guess three year even get talk know confidence getting back mids kind come pl thanksdan scavilla executive vice president chief commercial officer president trauma confident confident think called year million going get think cadence important think prepared comment talk manufacturing operation longer lead time item thing sga rd happen quickly think million would say give take going cog going come rd sga plant seed future manufacturing improvement drive improved pl profitability mean mean thing going pay attention year especially get back half year cashflow renegotiating contract see improvement working capital inventory buying raw material cheaper buying thing bringing inhouse equipment investing coming online producing inventory building inventory sell later going see lot benefit going really perspective view getting back mids right feel good thatoperatorthank one moment next question next question come matt taylor jefferies line openmatt taylor jefferies analyst hi guy thanks taking question wanted ask two kind side item one thought interesting bought back stock q maybe could talk decision whether opportunistic know said talking priority aaos talking ortho robot know could see later year guess question would expect contribution material year maybe next yeardan scavilla executive vice president chief commercial officer president trauma hey matt dan actually answer hand keith know look think market overreacted stock price actually deal going take opportunity use strong cash buy back reduce dilution actually set reason yeah opportunistic also plan keep believe strongly going go play long term use advantage would first one know aaos robot really happy said filed yet approved think going second half year would tell would expect material move think going storykeith pfeil chief operating officer chief financial officer really really lot add dans comment think hit head therematt taylor jefferies analyst thanksoperatorthank one moment next question next question come ryan zimmerman btig line openryan zimmerman btig analyst hey guy thanks taking question want follow maybe matt question different way know take kind prior number keith think called billion know look guidance land backing dissynergies come three percent fy guess curious kind view market relative number know market growing rate market growing faster rate feel like know coming aaos know early part year market pretty healthy know suggesting guy growing market growing maybe slightly market know second point question think guidance old model different segment know one company maybe help u piece together kind see growth coming within cervical within know support neuromonitoring international component beyond maybe musculoskeletal enabling tech willing comment would helpfulkeith pfeil chief operating officer chief financial officer yeah thanks ryan question think growth perspective commented earlier previous question legacy sale team would looking know legacy nuvasive side excited sell globus expendable cage globus enabling technology legacy globus focused lateral procedure thing nature think internationally think go back look historical nuvasive globus number think pretty good clip growing share internationally would expect see spinal implant continue see growth moving forward trauma know trauma legacy trauma business continues perform well nuvasive product portfolio think together going better together drive share growth think enabling tech get back crossselling opportunity brings back yous spine really initial question talked little bit know growth seen growing know early going dissynergies called million gross dissynergy growth rate clearly slowing first portion year dans point getting first second quarter really working move toward steady state getting second half year moving forward still fully believe provide mid high singledigit growth acknowledging first year going dissynergiesdan scavilla executive vice president chief commercial officer president trauma yeah think ryan fun thing back point growth going say everywhere right got great cervical disc leverage got egps ed neuro know monitoring system go apply business crossselling lot could go think looking healthy growth throughout portfolio really showing way versus focused one two area concentrationryan zimmerman btig analyst ok appreciate answering multipart question going squeeze one appreciate taking question late party aaos see chance go booth see new know component feel like largest competitor within robotics moving little bit term cranial clickability term ability maybe move thing like bone cutting right curious kind think know robotics going particularly within spine feel like hitting ceiling within applicability within maybe core spinal robotics application venture beyond area like cranial know joint reconstruction etc seeing kind pipeline product offering nowdan scavilla executive vice president chief commercial officer president trauma great question couple thing cranial long time robot great capability absolutely room expand think said one thing called excited array power solution bringing forward near term also work well enabling technology enhance surgeon experience mean really talk spinal robot infancy penetration capability long journey increasing entire procedural application bone soft tissue removal inner body placement planning year come lot space like said even combined u combined really touching robotics lot room growth come many year think anywhere near hitting top flattening think start amazing changing technologyryan zimmerman btig analyst thank danoperatorone moment next question next question come line jason wittes roth line openjason wittes roth mkm analyst hi thanks taking question could revisit synergy number based earlier comment sound like kind took midpoint dissynergies think partly due fact based see also know see happens next two quarter right way think came number trying understand know thought process behind thatkeith pfeil chief operating officer chief financial officer yesjason wittes roth mkm analyst ok fair term quarterly cadence help u term think revenue also expenditure kind flow yearkeith pfeil chief operating officer chief financial officer going break provide quarterly guidance pointjason wittes roth mkm analyst ok general standpoint think kind implied know first half sound based comment made guess throughout call sound like somewhat backend loaded meaning going fair amount still reorganization first half lot guess already occurred term ability start picking gaining market share sound like kind anticipate end year going positioned start know growing sort market market leader fair way think itkeith pfeil chief operating officer chief financial officer fair way think relates cost energy specifically would expect see improve sequentially get throughout yearjason wittes roth mkm analyst ok helpful thank muchkeith pfeil chief operating officer chief financial officer welcomeoperatoroperator instruction one moment next question next question come craig bijou bank america security line opencraig bijou bank america merrill lynch analyst great thanks taking question guy wanted ask first million revenue dissynergies appreciate gave u number think expecting roughly maybe year one wanted kind reconcile could still incremental synergy year two year three postdealkeith pfeil chief operating officer chief financial officer would say yes could incremental synergy year two year three postdeal really taking refreshed look mean commented point time thought good number still think generally speaking overall good document looked building plan current information felt like reasonable number based seeing gross perspectivedan scavilla executive vice president chief commercial officer president trauma craig would add one thought type activity occurs upfront early year crosssale gain traction offset year two probably time exit year three put bat way upfront crossselling growth offset outer year coming neutral time enter fourth yearkeith pfeil chief operating officer chief financial officer timing also deal actually close little bit laterdan scavilla executive vice president chief commercial officer president trauma yeahkeith pfeil chief operating officer chief financial officer also little bit impactcraig bijou bank america merrill lynch analyst ok helpful guy follow specifically embedded eps guidance know heard comment ebitda wanted see mean math make look like ebitda margin also wanted see assumption share buyback eps guidancekeith pfeil chief operating officer chief financial officer think make lot sense million share projected year leave thatcraig bijou bank america merrill lynch analyst ok thanks guyskeith pfeil chief operating officer chief financial officer thank youoperatorone moment next question next question come caitlin cronin canaccord line opencaitlin cronin canaccord genuity analyst hi thanks taking question regarding ar headset update timing secondly think current competition space product going competitive offeringsdan scavilla executive vice president chief commercial officer president trauma caitlin expect augmented reality headset xr get midyear based everything tracking toward right pretty excited well working make sure really work seamlessly enabling tech activity well actually create stronger offering surgeonscaitlin cronin canaccord genuity analyst great thank youoperatorthank one moment next question next question come line richard newitter truist line openrichard newitter truist security analyst right thanks taking question hoping go back comment made sound like going little bit heavy offense rep hiring nutrition think said something know hiring many rep normal fourth quarter hired rep net rep guess help understand mean relative good quarter net hiring supposed kind interpret relative dissynergies starting unfold followupdan scavilla executive vice president chief commercial officer president trauma got rich let u start way great recruiting year would tell ok recruiting year reason ok focus shifted making merger happen naturally level recruiting focus recruiting quite heavy mean dismal mean really different last five year strongest record year like normally call replying fact closed deal september globus actually inherited took merger roughly sale rep nuvasive business commentrichard newitter truist security analyst ok thanks figured something tongue cheek ok sorry lost train thought second wanted also get sense kind information going provide goforward basis seen press release divisional breakout going see going know historical provide segment detail think one last one product rationalization effort begunkeith pfeil chief operating officer chief financial officer thanks rich keith put reporting perspective going continue provide breakout musculoskeletal enabling well yous versus international continue provide color quarter business like always done historically relates product rationalization something really looked point know earlier comment focused need u listen customer right thing focused bringing sale force together listening surgeon listening patient really selling product companiesdan scavilla executive vice president chief commercial officer president trauma yeah rich would add planned rationalization thought time surgeon customer select want migrate toward product rationalization way reach achieve synergy anything financialsrichard newitter truist security analyst thank youoperatorone moment next question next question come line drew ranieri morgan stanley line opendrew ranieri morgan stanley analyst hi guy thanks taking question piggyback already asked rich last question product rationalization maybe hit upon thinking free cash flow generation next two three year investor think cash generation think one kind hallmark deal initially proposed anything changed thinking tracking driving instrument set utilization kind two well two company anymore legacy gmed nuvasive looking ahead followupdan scavilla executive vice president chief commercial officer president trauma drew go first dan hand keith clarity cash flow estimate anything built related rationalization want make sure building rich agree pursuing product rationalization built finance way effect financially cash flowwise however place way utilize field asset set efficiently working ever improving globus legacy intend nuvasive team get get speed going allow u get surgery turn output investment point generate figureable cash flow generating sale current level investment needed get saleskeith pfeil chief operating officer chief financial officer couple comment would add think globus yes going focus driving business managing cash think million know predominantly cash saving translate cash flow move forward part one part two really control capex go back look compare legacy globus nuvasive see legacy nuva carried capex probably closer sale globus give take commented going land year prepared remark also going help drive cash flow free cash flow generation going impact ability invest rd really going come back perspective perspective better control asset driving improved return invested capitaldrew ranieri morgan stanley analyst got thanks quick followup anything getting nuvasive product registered approved excelsius looking ahead thanks taking dan scavilla executive vice president chief commercial officer president trauma yeah definitely one key thing course going ever growing way starting reline system certainly look inaudible different activity way going one event think midyear within third quarter capable going pushing forward onoperatorthank question concludes globus medical earnings call thank participating operator signoff duration minutescall participantsbrian kearns senior vice president business development investor relationsdan scavilla executive vice president chief commercial officer president traumakeith pfeil chief operating officer chief financial officervik chopra well fargo security analyststeve lichtman oppenheimer company analystmathew blackman stifel financial corp analystshagun singh rbc capital market analystdavid saxon needham company analystmatt miksic barclays analystmatt obrien piper sandler analystmatt taylor jefferies analystryan zimmerman btig analystjason wittes roth mkm analystcraig bijou bank america merrill lynch analystcaitlin cronin canaccord genuity analystrichard newitter truist security analystdrew ranieri morgan stanley analyst gmed analysis earnings call transcript article transcript conference call produced motley fool strive foolish best may error omission inaccuracy transcript article motley fool assume responsibility use content strongly encourage research including listening call reading company sec filing please see term condition additional detail including obligatory capitalized disclaimer liabilitythe motley fool position recommends globus medical motley fool disclosure policy